LGND
Ligand Pharmaceuticals Incorporated · $287.54 (-3.0%) · mkt cap $5.8B · P/E 37.4

1 hub catalysts across 1 sources · backtest → · ← Ticker Explorer

U.S. House — Congressional Trades

Signal summary

Signals diverge

Bullish and bearish forces are in conflict here — weigh both columns.

34▲ Bullishconviction from hub signals
Bullish factors
  • Congress bought (1)
Bearish factors
  • Insiders net selling (12 vs 3)

Best strategy

2-yr backtest · by Sharpe

Price vs 200-day MA has fit LGND best over 2 years (+134.4%, Sharpe 1.65). Historical/in-sample — walk-forward all 19 →

#StrategyReturnSharpeBeats B&H
1Price vs 200-day MA+134.4%1.65
2Absolute Momentum (12mo)+112.8%1.61
3Buy & Hold (baseline)+175.7%1.52

Price — 1 year

daily close
$322.61$132.72$287.54 (+116.7% 1Y)

Insider activity

3 open-market buys

Officers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.

DateActionInsiderSharesValue
2026-07-01SELLReardon Andrew Thomas5,000$1.6M
2026-06-16SELLSabba Stephen L.2,145$545K
2026-06-12SELLHaas Jason6,461$1.7M
2026-06-11SELLAryeh Jason M5,000$1.2M
2026-06-10SELLLamattina John L4,591$1.2M
2026-06-01SELLReardon Andrew Thomas5,000$1.1M
2026-05-13SELLKozarich John W.2,501$563K
2026-05-01SELLReardon Andrew Thomas5,000$1.2M
2026-04-01SELLReardon Andrew Thomas5,000$1.0M
2026-04-01SELLKozarich John W.467$94K
2026-03-23SELLSabba Stephen L.1,000$208K
2026-03-11SELLEspinoza Octavio3,057$688K
2025-05-09BUYDavis Todd Clifton9,510$1.0M
2025-05-09BUYEspinoza Octavio1,500$156K
2024-08-08BUYDavis Todd Clifton2,500$243K

Analyst ratings

live · 3 changes
DateActionAnalystRating Change
2026-03-11InitiatedB of A SecuritiesBuy
2025-12-09InitiatedCitigroupBuy
2025-04-10InitiatedStifelBuy

Catalyst timeline

1 hub signals
DateSourceEventEntityValue
2026-05-29U.S. House — Congressional TradesCongress BUYHon. Gilbert Cisneros$1,001 - $15,000source ↗
Alt-Data Signal Hub · collected signals updated 2026-06-10 18:41 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice

All pages

Catalyst EdgeCongressNewsEarningsSEC FilingsHedge FundsLockupsPositioningMarket cycleBacktestOptionsSourcesGlossaryAbout & API